Human embryonic stem cells: Long term stability, absence of senescence and a potential cell source for neural replacement

Neuroscience

Volumn 145, Issue 4, 2007, Pages 1348-1358

  Zeng, X ^a   Rao, M S ^b,c  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INVITROGEN CORPORATION   (United States)

Author keywords

epigenetic; hESC; karyotype; neural aging; senescence; telomerase

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE;

ALZHEIMER DISEASE; CELL AGING; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEGENERATIVE DISEASE; DNA REPAIR; EMBRYONIC STEM CELL; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; NERVE REGENERATION; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC CELL; SPINAL CORD INJURY; TELOMERE;

CELL AGING; CENTRAL NERVOUS SYSTEM DISEASES; DNA REPAIR; DNA, MITOCHONDRIAL; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; GENOMIC INSTABILITY; HUMANS; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TELOMERASE;

EID: 34247177103     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.09.017     Document Type: Review

References (99)

1. Aladjem M.I., Spike B.T., Rodewald L.W., Hope T.J., Klemm M., Jaenisch R., and Wahl G.M. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8 (1998) 145-155
2. Amit M., Carpenter M.K., Inokuma M.S., Chiu C.P., Harris C.P., Waknitz M.A., Itskovitz-Eldor J., and Thomson J.A. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 227 (2000) 271-278
3. Bargonetti J., and Manfredi J.J. Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14 (2002) 86-91
4. Baylin S.B., and Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16 (2000) 168-174
5. Berneburg M., Kamenisch Y., and Krutmann J. Repair of mitochondrial DNA in aging and carcinogenesis. Photochem Photobiol Sci 5 (2006) 190-198
6. Bianchi N.O., Bianchi M.S., and Richard S.M. Mitochondrial genome instability in human cancers. Mutat Res 488 (2001) 9-23
7. Blackburn E.H. Structure and function of telomeres. Nature 350 (1991) 569-573
8. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet 6 (2005) 611-622
9. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
10. Bohr V.A., and Dianov G.L. Oxidative DNA damage processing in nuclear and mitochondrial DNA. Biochimie 81 (1999) 155-160
11. Brandenberger R., Khrebtukova I., Thies R.S., Miura T., Jingli C., Puri R., Vasicek T., Lebkowski J., and Rao M. MPSS profiling of human embryonic stem cells. BMC Dev Biol 4 (2004) 10
12. Brimble S.N., Zeng X., Weiler D.A., Luo Y., Liu Y., Lyons I.G., Freed W.J., Robins A.J., Rao M.S., and Schulz T.C. Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13 (2004) 585-597
13. Buzzard J.J., Gough N.M., Crook J.M., and Colman A. Karyotype of human ES cells during extended culture. Nat Biotechnol 22 (2004) 381-382 author reply 382.
14. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
15. Carpenter M.K., Rosler E.S., Fisk G.J., Brandenberger R., Ares X., Miura T., Lucero M., and Rao M.S. Properties of four human embryonic stem cell lines maintained in a feeder-free culture system. Dev Dyn 229 (2004) 243-258
16. Chen J. Senescence of hematopoietic stem cells and bone marrow failure. Int J Hematol 82 (2005) 190-195
17. Classon M., and Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2 (2002) 910-917
18. Cong Y.S., Wen J., and Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet 8 (1999) 137-142
19. Corbet S.W., Clarke A.R., Gledhill S., and Wyllie A.H. P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene 18 (1999) 1537-1544
20. Correia A.S., Anisimov S.V., Li J.Y., and Brundin P. Stem cell-based therapy for Parkinson's disease. Ann Med 37 (2005) 487-498
21. de Magalhaes J.P., and Church G.M. Genomes optimize reproduction: aging as a consequence of the developmental program. Physiology (Bethesda) 20 (2005) 252-259
22. Di Leonardo A., Linke S.P., Clarkin K., and Wahl G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8 (1994) 2540-2551
23. Do J.T., and Scholer H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22 (2004) 941-949
24. Draper J.S., Smith K., Gokhale P., Moore H.D., Maltby E., Johnson J., Meisner L., Zwaka T.P., Thomson J.A., and Andrews P.W. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22 (2004) 53-54
25. Duncan I.D. Oligodendrocytes and stem cell transplantation: their potential in the treatment of leukoencephalopathies. J Inherit Metab Dis 28 (2005) 357-368
26. Evans M.J., and Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292 (1981) 154-156
27. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
28. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., et al. The RNA component of human telomerase. Science 269 (1995) 1236-1241
29. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., and Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287 (2000) 2017-2019
30. Forsyth N.R., Wright W.E., and Shay J.W. Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69 (2002) 188-197
31. Fukuda H., and Takahashi J. Embryonic stem cells as a cell source for treating Parkinson's disease. Expert Opin Biol Ther 5 (2005) 1273-1280
32. Ginis I., Luo Y., Miura T., Thies S., Brandenberger R., Gerecht-Nir S., Amit M., Hoke A., Carpenter M.K., Itskovitz-Eldor J., and Rao M.S. Differences between human and mouse embryonic stem cells. Dev Biol 269 (2004) 360-380
33. Grundy P.E., Breslow N.E., Li S., Perlman E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., D'Angio G.J., Donaldson M., Coppes M.J., Malogolowkin M., Shearer P., Thomas P.R., Macklis R., Tomlinson G., Huff V., and Green D.M. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23 (2005) 7312-7321
34. Hayflick L. The cell biology of human aging. N Engl J Med 295 (1976) 1302-1308
35. Hayflick L., and Moorhead P.S. The serial cultivation of human diploid cell strains. Exp Cell Res 25 (1961) 585-621
36. Heins N., Englund M.C., Sjoblom C., Dahl U., Tonning A., Bergh C., Lindahl A., Hanson C., and Semb H. Derivation, characterization, and differentiation of human embryonic stem cells. Stem Cells 22 (2004) 367-376
37. Hodgson J.G., Chin K., Collins C., and Gray J.W. Genome amplification of chromosome 20 in breast cancer. Breast Cancer Res Treat 78 (2003) 337-345
38. Hofmann W.K., Tsukasaki K., Takeuchi N., Takeuchi S., and Koeffler H.P. Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma. Leuk Lymphoma 42 (2001) 1107-1109
39. Horikawa I., Cable P.L., Afshari C., and Barrett J.C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59 (1999) 826-830
40. Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23 (2002) 687-696
41. Jansen R.P. Origin and persistence of the mitochondrial genome. Hum Reprod 15 Suppl 2 (2000) 1-10
42. Jiang X.R., Jimenez G., Chang E., Frolkis M., Kusler B., Sage M., Beeche M., Bodnar A.G., Wahl G.M., Tlsty T.D., and Chiu C.P. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 21 (1999) 111-114
43. Kang J.H., Kim S.J., Noh D.Y., Park I.A., Choe K.J., Yoo O.J., and Kang H.S. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 81 (2001) 573-579
44. Kirkwood T.B., and Austad S.N. Why do we age?. Nature 408 (2000) 233-238
45. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., and Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12 (1998) 3008-3019
46. Mahlamaki E.H., Barlund M., Tanner M., Gorunova L., Hoglund M., Karhu R., and Kallioniemi A. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 35 (2002) 353-358
47. Maitra A., Arking D.E., Shivapurkar N., Ikeda M., Stastny V., Kassauei K., Sui G., Cutler D.J., Liu Y., Brimble S.N., Noaksson K., Hyllner J., Schulz T.C., Zeng X., Freed W.J., Crook J., Abraham S., Colman A., Sartipy P., Matsui S., Carpenter M., Gazdar A.F., Rao M., and Chakravarti A. Genomic alterations in cultured human embryonic stem cells. Nat Genet 37 (2005) 1099-1103
48. Maser R.S., and DePinho R.A. Connecting chromosomes, crisis, and cancer. Science 297 (2002) 565-569
49. Mateizel I., De Temmerman N., Ullmann U., Cauffman G., Sermon K., Van de Velde H., De Rycke M., Degreef E., Devroey P., Liebaers I., and Van Steirteghem A. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21 (2006) 503-511
50. Mitalipova M., Calhoun J., Shin S., Wininger D., Schulz T., Noggle S., Venable A., Lyons I., Robins A., and Stice S. Human embryonic stem cell lines derived from discarded embryos. Stem Cells 21 (2003) 521-526
51. Mitalipova M.M., Rao R.R., Hoyer D.M., Johnson J.A., Meisner L.F., Jones K.L., Dalton S., and Stice S.L. Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23 (2005) 19-20
52. Miura T., Luo Y., Khrebtukova I., Brandenberger R., Zhou D., Thies R.S., Vasicek T., Young H., Lebkowski J., Carpenter M.K., and Rao M.S. Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. Stem Cells Dev 13 (2004) 694-715
53. Miura T., Mattson M.P., and Rao M.S. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3 (2004) 333-343
54. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
55. Oren M., and Rotter V. Introduction: p53-the first twenty years. Cell Mol Life Sci 55 (1999) 9-11
56. Pennisi E. Behind the scenes of gene expression. Science 293 (2001) 1064-1067
57. Peterson C.L., and Cote J. Cellular machineries for chromosomal DNA repair. Genes Dev 18 (2004) 602-616
58. Plaia T.W., Josephson R., Liu Y., Zeng X., Ording C., Toumadje A., Brimble S.N., Sherrer E.S., Uhl E.W., Freed W.J., Schulz T.C., Maitra A., Rao M.S., and Auerbach J.M. Characterization of a new NIH registered variant human embryonic stem cell line BG01V: A tool for human embryonic stem cell research. Stem Cells 24 (2005) 531-536
59. Popescu N.C., and Zimonjic D.B. Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 6 (2002) 151-159
60. Prinzinger R. Programmed ageing: the theory of maximal metabolic scope. How does the biological clock tick?. EMBO Rep 6 (2005) S14-S19
61. Prost S., Bellamy C.O., Clarke A.R., Wyllie A.H., and Harrison D.J. p53-Independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett 425 (1998) 499-504
62. Puzianowska-Kuznicka M., and Kuznicki J. Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing?. Int J Biochem Cell Biol 37 (2005) 947-960
63. Razin A., and Kantor B. DNA methylation in epigenetic control of gene expression. Prog Mol Subcell Biol 38 (2005) 151-167
64. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18 (2000) 399-404
65. Rosler E.S., Fisk G.J., Ares X., Irving J., Miura T., Rao M.S., and Carpenter M.K. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 229 (2004) 259-274
66. Rugg-Gunn P.J., Ferguson-Smith A.C., and Pedersen R.A. Epigenetic status of human embryonic stem cells. Nat Genet 37 (2005) 585-587
67. Salozhin S.V., Prokhorchuk E.B., and Georgiev G.P. Methylation of DNA: one of the major epigenetic markers. Biochemistry (Mosc) 70 (2005) 525-532
68. Saretzki G., Armstrong L., Leake A., Lako M., and von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 22 (2004) 962-971
69. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
70. Sethe S., Scutt A., and Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 5 (2005) 91-116
71. Shay J.W., and Wright W.E. Mechanism-based combination telomerase inhibition therapy. Cancer Cell 7 (2005) 1-2
72. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Genes Dev 12 (1998) 2984-2991
73. Sherratt E.J., Thomas A.W., and Alcolado J.C. Mitochondrial DNA defects: a widening clinical spectrum of disorders. Clin Sci (Lond) 92 (1997) 225-235
74. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., Jensen T.G., and Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20 (2002) 592-596
75. Singh K.K. Mitochondria damage checkpoint, aging, and cancer. Ann N Y Acad Sci 1067 (2006) 182-190
76. Smith J.R., and Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science 273 (1996) 63-67
77. Smogorzewska A., van Steensel B., Bianchi A., Oelmann S., Schaefer M.R., Schnapp G., and de Lange T. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20 (2000) 1659-1668
78. Sonntag K.C., and Sanchez-Pernaute R. Tailoring human embryonic stem cells for neurodegenerative disease therapy. Curr Opin Investig Drugs 7 (2006) 614-618
79. Stewart S.A. Telomere maintenance and tumorigenesis: an "ALT"ernative road. Curr Mol Med 5 (2005) 253-257
80. Stirzaker C., Millar D.S., Paul C.L., Warnecke P.M., Harrison J., Vincent P.C., Frommer M., and Clark S.J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 57 (1997) 2229-2237
81. Takakura M., Kyo S., Kanaya T., Hirano H., Takeda J., Yutsudo M., and Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59 (1999) 551-557
82. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., and Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
83. Trifunovic A. Mitochondrial DNA and ageing. Biochim Biophys Acta 1757 (2006) 611-617
84. Van Sloun P.P., Jansen J.G., Weeda G., Mullenders L.H., van Zeeland A.A., Lohman P.H., and Vrieling H. The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res 27 (1999) 3276-3282
85. van Steensel B., and de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 385 (1997) 740-743
86. Wadhwa R., Kaul S.C., and Mitsui Y. Cellular mortality to immortalization: mortalin. Cell Struct Funct 19 (1994) 1-10
87. Wakayama T. Cloned mice and embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Oncol Res 13 (2003) 309-314
88. Wang Q., Matsumoto Y., Shindo T., Miyake K., Shindo A., Kawanishi M., Kawai N., Tamiya T., and Nagao S. Neural stem cells transplantation in cortex in a mouse model of Alzheimer's disease. J Med Invest 53 (2006) 61-69
89. Wang Y., Michikawa Y., Mallidis C., Bai Y., Woodhouse L., Yarasheski K.E., Miller C.A., Askanas V., Engel W.K., Bhasin S., and Attardi G. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A 98 (2001) 4022-4027
90. Warner H.R. Recent progress in understanding the relationships among aging, replicative senescence, cell turnover and cancer. In Vivo 16 (2002) 393-396
91. Westermann F., and Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 184 (2002) 127-147
92. Wilmut I., Beaujean N., de Sousa P.A., Dinnyes A., King T.J., Paterson L.A., Wells D.N., and Young L.E. Somatic cell nuclear transfer. Nature 419 (2002) 583-586
93. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., and Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 385 (1997) 810-813
94. Wolffe A.P., and Matzke M.A. Epigenetics: regulation through repression. Science 286 (1999) 481-486
95. Yakes F.M., and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A 94 (1997) 514-519
96. Yang J., Chang E., Cherry A.M., Bangs C.D., Oei Y., Bodnar A., Bronstein A., Chiu C.P., and Herron G.S. Human endothelial cell life extension by telomerase expression. J Biol Chem 274 (1999) 26141-26148
97. Zeng X., Chen J., Liu Y., Luo Y., Schulz T.C., Robins A.J., Rao M.S., and Freed W.J. BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor Neurol Neurosci 22 (2004) 421-428
98. Zeng X., and Rao M.S. The therapeutic potential of embryonic stem cells: A focus on stem cell stability. Curr Opin Mol Ther 8 (2006) 338-344
99. Zheng L., and Lee W.H. Retinoblastoma tumor suppressor and genome stability. Adv Cancer Res 85 (2002) 13-50